From the therapeutic class to the clinical paradigm to the two distribution tiers. The taxonomy of the discipline.
The compounds of endogenic pharmacology. Short peptide bioregulators of the Khavinson lineage, proprietary acetylated and amidated analogs (Ac-X-NH2 dual-terminus modified compounds), and combinations with co-administered agents.
Read →The clinical practice of endogenic pharmacology. Translates the principles of endogenous regulation into therapeutic protocols across neurological, immune, vascular, longevity, and metabolic indications.
Read →Bioregulator-based products formulated for over-the-counter consumer access. Topical, transdermal, intranasal, sublingual, and oral delivery formats supporting wellness, longevity, and tissue-specific maintenance.
Read →Bioregulator-based therapeutics formulated for prescription clinical use. Pharmacy-compounded and FDA-pathway preparations for clinically supervised endogenic intervention.
Read →